WATERMARK Research Partners
Watermark Researh Partners, Inc provides Independent Data Monitoring, post-market safety oversight, outcome registries and adjudication services for the pharmaceutical, biotech and medical device industry. [1]
 | |
| | |
| Watermark Research Partners, Inc | |
|---|---|
| Type | Private |
| Industry | Researsh |
| Headquarters | 8123 Castleton Road, Indianapolis, IN 46250 United States |
| Key people | CEO/Founder: Dr. Barbara Schneider, Ph.D, MBA
Director of Operations: Ms. Georgia Pate Director of Business Development: Ms. Robin Piazza |
| Number of employees | 11-50 employees |
Contents
Overview
Watermark is the first independent central DSMB.
The company provide the essentials to establishing, conducting, and supporting DSMB and adjudication panels. Watermark keeps you completely independent and supports the board members by providing all the service to make the meetings autonomous, efficient, and an unbiased review; which is critical to the success of your clinical trial. If you are ever audited, Watermark’s archived records prove that the DSMB and adjudication panel were reviewers independent of the sponsor company.
Controversies
Top 5 Recent Tweets
| Date | Author | Comment |
|---|---|---|
| February 20, 2023 | UoNresearch | The Public Engagement Watermark demonstrates our commitment to public engagement to staff, students, communities, p… https://t.co/nKt8sxFD2x |
Top 5 Recent News Headlines
Top 5 Lifetime Tweets
Top 5 Lifetime News Headlines
References
https://www.bloomberg.com/profiles/companies/0728447D:US-watermark-research-partners-inc
http://www.watermarkresearch.com/
http://www.watermarkresearch.com/clinical-trial-safety
Verification history
2,690 days ago
2,693 days ago- View all verifications
